Viral Conjunctivitis Drugs Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

The global viral conjunctivitis drugs market is anticipated to grow at a significant CAGR during the forecast period. The market is projected to show substantial growth owing to the high number of people suffering from viral conjunctivitis as well as eye-related allergies followed by the easier availability of the necessary treatment across the globe. Although the disease is very common, treatment for it is easily available globally. Generally, viral conjunctivitis is self diagnosable and there is the minimum need of undergoing any diagnostic test for it.

Emerging economies such as India also witnessed a high prevalence of the disease. According to an article published by the journal, Clinical Epidemiology and Global Health, it was discovered that during the year 2019, the prevalence of allergic conjunctivitis was around 12.22% and the number of men suffering from this disease is higher than that of women in India. The epidemiology of the disease is similar in other Asian countries such as China. Hence, due to the high prevalence of the disease, the market is projected to have a steady growth during the forecast period. Furthermore, some key players operating in the market include AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.

To Request a Sample of our Report on Viral Conjunctivitis Drugs Market:  https://www.omrglobal.com/request-sample/viral-conjunctivitis-drugs-market

Market Coverage

·        The market number available for – 2022-2030

·        Base year- 2022

·        Forecast period- 2023-2030

·        Segment Covered

·        Regions Covered- Globally

Competitive Landscape: AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Bausch Health Co. Inc., among others.

Viral Conjunctivitis Drugs Market by Segment

By Drug Class 

•                 Artificial tears

•                 Decongestants

•                 Anti-histamines

•                 NSAIDS

•                 Anti-Viral drugs

•                 Steroids

•                 Antibiotics

By Virus Type 

•             Adenovirus

•             Enterovirus

•             Others

By Distribution Channel 

•             Hospital Pharmacies

•             Retail Pharmacies

•             Online Pharmacies

A full Report of Viral Conjunctivitis Drugs Market is Available @  https://www.omrglobal.com/industry-reports/viral-conjunctivitis-drugs-market

 Viral Conjunctivitis Drugs Market by Region

North America

·        United States

·        Canada

Europe

·        UK

·        Germany

·        Spain

·        France

·        Italy

·        Rest of Europe

Asia-Pacific

·                  India

·                  China

·                  Japan

·                  South Korea

·                  Rest of APAC

Rest of the World

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/viral-conjunctivitis-drugs-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404